Treating Cancer With Precision
Home
Alpha DaRT
Treatment
Clinical Trials
Publications
About
Investors
More
Read article and watch video here
Alpha Tau Announces Treatment of First Prostate Cancer Patient with Alpha DaRT™
FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT™ in Recurrent Cutaneous SCC
Alpha Tau Announces Resignation of Gary Leibler from its Board of Directors
